BioNTech SE - ADR

NASDAQ:BNTX  
147.42
-9.11 (-5.82%)
4:50:20 PM EDT: $147.00 -0.42 (-0.29%)
Products

BioNTech, Pfizer Submit SBLA To USFDA To Expand Nod Of Comirnaty To Include 12-15 Age Category

Published: 12/17/2021 13:59 GMT
BioNTech SE - ADR (BNTX) - Biontech Se - Pfizer, Co Submitted a Sbla to Usfda to Expand Approval of Comirnaty to Include Individuals Aged 12 Through 15 Years.
Biontech Se - Pfizer and Biontech Intend to File Data With Ema and Other Regulatory Authorities Around the World in the Coming Weeks.
Further Company Coverage: [22uay.
De].
((reuters.
Briefs@thomsonreuters.
Com;)).